http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2318210-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92e4a950dfbe61eac5d4eaf36dd1014c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e90d58c51daa83968fb6cc8152fb40a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6f5cfaa04ecadbf9353f3f04fc19f63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfa357414fbfbed386d8d7c86a3fab6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd30fe9aae8c6de4b1d3aa3a4d9f825b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57cbb85ee3993e0b648185f744241a12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71549047276ecf7db323fd820c000072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3815c92c3a3d3e67779b3113518a366 |
| publicationDate | 2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2318210-C1 |
| titleOfInvention | Method for predicting minor abnormalities in the development of fetal heart at intrauterine viral infectioning |
| abstract | FIELD: medicine, obstetrics. n SUBSTANCE: in female peripheral venous blood at intrauterine infectioning, in the second trimester of pregnancy it is necessary to detect the concentration of MMP-1, MMP-3, antibodies to cardiolipin of IgG class, C-reactive protein, CPK Cor CK to calculate discriminant function (Y) by the following formula: Y=125-7.5×A-7.7×B-36.2×C-0.8×D-0.2×E, where A - the value of MMP-1 (ng/mL); B - the value of MMP-3 (ng/mL); C - the value of C-reactive protein (mg/dL); D - the value of antibody to cardiolipin of IgG class (GPL U/ml); E - the value of CPK Cor CK (U/l). In case of Y<0 one should diagnose minor abnormalities in the development of fetal heart at accuracy being 92.0%, specificity being 100%, sensitivity being 85.7%. The innovation provides the chance to carry out complex biochemical trial to diagnose minor abnormalities in the development of fetal heart in case of intrauterine viral infectioning. n EFFECT: higher accuracy of diagnostics. n 4 ex, 1 tbl |
| priorityDate | 2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.